A Study of Mood and Stress After Spinal Cord Injury

Depression Clinical Trial

Official title:

A Survey of Vulnerability Factors, Current Stress and Depression Risk in Spinal Cord Injury

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01337908
• Other study ID #: H133G070020
• Status: Completed
• Phase: N/A
• First received: April 15, 2011
• Last updated: March 19, 2012
• Start date: February 2009
• Est. completion date: September 2011

Study information

• Verified date: March 2012
• Source: University of Michigan
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

This is a study of factors, such as pain, family support, psychological history and alcohol/substance use, that may influence whether a person experiences depression after their spinal cord injury.

Description:

The objective of this study is to examine the degree to which vulnerability factors are mediated by stress to increase risk for depression after SCI in a sample of adults who sustained their injuries after the age of 18 years. Participants will complete a written survey (about pain, daily activities, social support and life experiences) and a telephone interview that will provide information about these factors.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 377
• Est. completion date: September 2011
• Est. primary completion date: September 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 19 Years and older

Eligibility

Inclusion Criteria:

• Have a spinal cord injury

• Were age 16 years or older when injured

• Sudden onset of symptoms

Exclusion Criteria:

• Under 19 years old

• Less than 1 year post-injury

• had a non-traumatic injury

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Depression
• Depressive Disorder
• Spinal Cord Injuries
• Spinal Cord Injury

Locations

Country	Name	City	State
United States	University of Michigan	Ann Arbor	Michigan
United States	Rehabilitation Institute of Michigan	Detroit	Michigan
United States	Santa Clara Valley Medical Center	San Jose	California
United States	University of Washington	Seattle	Washington

Sponsors (4)

Lead Sponsor	Collaborator
University of Michigan	Santa Clara Valley Health & Hospital System, University of Washington, Wayne State University

Country where clinical trial is conducted

United States,